MEDVi vs Hims: GLP-1 Program Comparison 2026

Bottom line: Hims is the stronger pick for most people looking at compounded GLP-1 therapy. It offers lower monthly pricing, a well-built app experience, and the brand recognition that comes with being one of the largest telehealth companies in the U.S. MEDVi, however, may appeal to patients who want a more clinically focused program with structured metabolic health tracking. If your priority is affordability and a smooth digital experience, Hims wins. If you value a physician-led approach with deeper health assessments, MEDVi is worth considering.

Quick Comparison

Pricing Breakdown

Hims generally undercuts MEDVi on price. The Hims GLP-1 program starts around $199/month for compounded semaglutide at lower doses, scaling up as doses increase. MEDVi's pricing begins closer to $249/month, and their higher-tier plans with tirzepatide can push past $399. For a complete cost breakdown, see our cheapest GLP-1 without insurance.

Both platforms include the provider consultation in their monthly pricing, which is standard practice across telehealth weight loss companies now. Neither typically requires a separate enrollment fee, though MEDVi has occasionally run programs with an initial assessment charge.

Where it gets interesting is what you get for that price. MEDVi bundles more thorough metabolic lab panels into its program, which adds clinical value but also explains the higher cost. Hims keeps its offering leaner: medication, provider access, and a strong digital platform. For patients who already have a primary care doctor managing their labs, the Hims approach avoids paying for services they don't need.

Medications Available

Both platforms focus on compounded semaglutide as their primary GLP-1 offering. Compounded tirzepatide availability fluctuates at both companies, depending on supply chain conditions and regulatory changes affecting 503A and 503B pharmacies.

Hims has the advantage of scale. As one of the largest telehealth providers in the country, it has established relationships with multiple compounding pharmacies, which can mean more consistent supply. MEDVi works with a smaller pharmacy network, which can occasionally lead to delays during periods of high demand.

Neither platform is a reliable source for brand-name Ozempic, Wegovy, or Mounjaro. If you specifically need brand-name medications, you'll likely need to work through a traditional provider and your insurance company.

Patient Experience

This is where Hims clearly pulls ahead. The Hims app is one of the better telehealth experiences available. Messaging your provider, tracking shipments, requesting refills, and reviewing treatment plans all happen in a single interface that feels modern and responsive.

MEDVi's platform is functional but less refined. The patient portal handles the basics (messaging, prescription management, appointment scheduling) without the polish of the Hims app. MEDVi compensates somewhat with what patients describe as more thorough initial consultations and follow-up appointments that feel less rushed.

For ongoing support, Hims offers 24/7 messaging with a care team, though responses can sometimes feel templated. MEDVi's communication tends to be more personalized but operates on business-hours response times.

Provider Quality and Support

MEDVi emphasizes its physician-led model, with board-certified doctors conducting consultations. Hims uses a broader provider network that includes nurse practitioners and physician assistants alongside MDs. For a straightforward GLP-1 prescription, the provider type matters less than some patients assume. NPs and PAs are fully qualified to prescribe and manage these medications.

Where MEDVi's physician focus might matter is for patients with complex medical histories or multiple comorbidities. Having a physician review your case from the start can provide an extra layer of clinical oversight.

Pros and Cons

MEDVi

Pros:

• Physician-led consultations with thorough initial assessments
• thorough metabolic lab panels included
• More personalized communication style
• Structured treatment protocols

Cons:

• Higher monthly pricing
• Less polished digital experience
• Smaller pharmacy network may mean occasional supply issues
• Limited state availability compared to Hims

Hims

Pros:

• Lower monthly cost
• Excellent app and digital experience
• Broad state availability
• Established brand with large provider network
• 30-day satisfaction guarantee

Cons:

• Provider interactions can feel brief or templated
• Less emphasis on thorough health assessments
• Mixed provider types (not always a physician)
• High patient volume can slow support response quality

Who Should Choose MEDVi

MEDVi makes sense for patients who want a more clinical, physician-driven experience. If you have existing health conditions that require careful monitoring, or if you want detailed lab work integrated into your weight loss program, MEDVi's approach adds genuine value. It's also a reasonable choice if you prefer the feel of working with a dedicated medical practice rather than a large consumer health platform.

Who Should Choose Hims

Hims is the better fit for most healthy adults who want an affordable, convenient path to compounded GLP-1 medication. If you already have a primary care doctor handling your general health and labs, you probably don't need MEDVi's bundled clinical services. The Hims app experience is genuinely good, and the lower price point makes long-term treatment more sustainable.

How FormBlends Compares

FormBlends operates in a different lane than either MEDVi or Hims. As a physician-supervised telehealth platform, FormBlends offers both GLP-1 weight loss medication and peptide wellness therapy. The physician-supervised model means every patient works directly with a licensed doctor, similar to MEDVi's approach but with broader treatment options that extend beyond weight loss into areas like recovery, energy, and metabolic improvement. Patients who want a single provider relationship covering both GLP-1 therapy and complementary peptide protocols may find FormBlends worth exploring at FormBlends.com.

Frequently Asked Questions

Is MEDVi cheaper than Hims for GLP-1 medication?

No. Hims is generally less expensive, with plans starting around $199/month compared to MEDVi's $249+ starting price. But MEDVi includes more thorough lab work, which could save money if you would otherwise pay for those tests out of pocket.

Do both platforms offer tirzepatide?

Both offer compounded tirzepatide when available. Supply can be inconsistent at either platform due to ongoing regulatory and supply chain factors in the compounding pharmacy space.

Can I use insurance with MEDVi or Hims?

Neither platform typically accepts insurance for their GLP-1 programs. Both are cash-pay services. Some patients use HSA or FSA funds to cover the cost.

Which platform has better customer support?

Hims offers more hours of availability and faster initial responses. MEDVi tends to provide more personalized, detailed responses but with slower turnaround. It depends on whether you prioritize speed or depth.

Ready to explore physician-supervised GLP-1 therapy with peptide wellness options? Learn what FormBlends offers and see if it fits your goals.